FOXO4-DRI 10mg peptide
FOXO4-DRI 10mg peptide: a research vial of FOXO4-DRI, a lab-built peptide studied in cells and mice in research on worn-out cells; its four papers, which Peptides Hanoi lists from 2017 to 2025, come from mice, cells and the lab bench, with none in people.
8,600,000 VND ($340 USD) for 1 vial
Stock and the total are confirmed on WhatsApp.
USD prices are the store's dollar prices; you pay the VND price.
Free tracked delivery to Hanoi in 1 to 3 days, no minimum order. Each vial comes with a bottle of bacteriostatic water and a container. Research use only: not an approved medicine, and no medical advice.
What is FOXO4-DRI?
FOXO4-DRI 10mg is a lab-built peptide aimed at worn-out cells. So far it has been studied only in the lab and in mice.
Its starting point is part of a protein called FOXO4. The amino acids are mirror images of the usual ones, placed in reverse order, a design that holds up against breakdown. An added sequence helps it slip inside cells.
The intended target is the senescent cell: an old cell that no longer divides yet does not die. The peptide was designed to push such cells to die.
What the 4 PubMed papers cited for FOXO4-DRI looked at, 2017 to 2025
The peptide was created and tested in 2017, in mice bred to age fast and in naturally old mice, with measures of senescent cells, fitness, coat and kidney function.
A 2023 study tested it in mice with scarred lungs, measuring lung damage and collagen. In 2025, a lab study added it to worn-out cells taken from keloids, the thick raised scars.
Also in 2025, a structure study mapped the way FOXO4-DRI grips the p53 protein, the basis of current thinking about how it works.
No human trial has been published. The studies here used cells, mice or the protein structure alone.
Sources: Cell 2017; Naunyn Schmiedebergs Arch Pharmacol 2023; Commun Biol 2025; Nat Commun 2025.
Reading the FOXO4-DRI record
The idea behind FOXO4-DRI is simple to state: push worn-out cells to die, then study the tissue around them. The 2017 mouse study tested that idea, and later studies tried it on lung scarring and on scar cells from keloids.
Every step so far is in the lab or in mice. The 2025 structure study explains how the peptide grips p53. That is a step toward understanding it, not a test of what it does in people.
Two terms appear in this research. Keloids are thick, raised scars, and the 2025 lab study used their worn-out cells. The extra sequence the peptide carries is there to help it get inside cells, which matters for a molecule built to act on a protein within them.
Questions about FOXO4-DRI
Has FOXO4-DRI been tested in people?
No. The work cited here covers cells, mice and the protein's structure, beginning with a 2017 study, and our search found no human trial.
What is the difference between FOXO4 and FOXO4-DRI?
FOXO4 is a natural protein inside cells. FOXO4-DRI is a short lab-made peptide copied from one part of it, built D-retro-inverso: mirror-image amino acids set in reverse order, so it resists breakdown.
What is a senescent cell?
An old cell that has stopped dividing but does not die. FOXO4-DRI was designed to push such cells to die.
FOXO4-DRI 10mg prices
| Pack | Total | Each vial | Per mg |
|---|---|---|---|
| 1 vial | 8,600,000 VND ($340 USD) | 8,600,000 VND ($340 USD) | 860,000 VND ($34.00 USD) |
| Pack of 3 | 20,898,000 VND ($826.20 USD) | 6,966,000 VND ($275.40 USD) | 696,600 VND ($27.54 USD) |
| Pack of 5 | 30,960,000 VND ($1,224 USD) | 6,192,000 VND ($244.80 USD) | 619,200 VND ($24.48 USD) |
| Pack of 10 | 51,600,000 VND ($2,040 USD) | 5,160,000 VND ($204 USD) | 516,000 VND ($20.40 USD) |
Near FOXO4-DRI in the list of 42
FOXO4-DRI follows SS-31 10mg and precedes Glutathione 600mg, the antioxidant that human cells make for themselves.
- Humanin 10mg, 4,700,000 VND ($185 USD) a vial
- SS-31 10mg, 3,000,000 VND ($120 USD) a vial
- Glutathione 600mg, 2,400,000 VND ($95 USD) a vial
- BPC-157 20mg, 3,500,000 VND ($138 USD) a vial